Results 171 to 180 of about 128,560 (293)

Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer. [PDF]

Clin Transl Med
Zhang S, Fu Q, Xu Z, Wang S, You G, Su X, Yuan X, Liu C, Liu C, Zhang C, Liu B, Gong Y.   +11 more
europepmc   +1 more source

Monitoring Group 2 Innate Lymphoid Cell Biology in Models of Lung Inflammation. [PDF]

Bio Protoc, 2023
Badrani JH, Strohm AN, Haung YA, Doherty TA.   +3 more
europepmc   +1 more source

Homocitrullinated Peptides Drive Pro‐Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Anti‐homocitrullinated protein/peptide antibodies are specific to rheumatoid arthritis (RA) and predictive of worse prognosis, suggesting a pathogenic role for autoreactivity to homocitrullinated peptides (HomoCitP). However, T cell responses to HomoCitP remain largely unexplored.
Sofya Ulanova, Jaspreet Kaur, Gabrielle Buckley, S. M. Mansour Haeryfar, Lisa Cameron, Ewa Cairns, Lillian Barra   +6 more
wiley   +1 more source

Innate lymphoid cell heterogeneity and etiology-specific reprogramming in hepatocellular carcinoma. [PDF]

NPJ Precis Oncol
Lee YH, Chuah S, Leow WQ, Hazirah SN, Wasser M, Chung A, Goh BKP, Chow PKH, Albani S, Lee J, Lim TKH, Dan YY, Lee SG, Tai D, Chen J, Liu H, Chew V.   +16 more
europepmc   +1 more source

Alteration of innate lymphoid cell homeostasis mainly concerns salivary glands in primary Sjögren's syndrome. [PDF]

RMD Open, 2023
Kawka L, Felten R, Schleiss C, Fauny JD, Le Van Quyen P, Dumortier H, Monneaux F, Gottenberg JE.   +7 more
europepmc   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

Regulatory B cell expansion and type 1 innate lymphoid cell suppression characterise immune modulation in paediatric lupus nephritis. [PDF]

RMD Open
Lin CY, Chien JW, Lin KH, Hsiao KH, Tien YC, Su TC, Wei CC, Fu LS, Yang KD, Kao JK, Tsai YG.   +10 more
europepmc   +1 more source

Reprogramming tumor immune microenvironment by ultrasound‐responsive nanoplatforms for enhanced cancer immunotherapy

BMEMat, EarlyView.
Ultrasound‐responsive nanoplatforms reprogram the tumor immune microenvironment by targeting tumor cells, immune cells, and non‐immune stromal cells to enhance the efficacy of cancer immunotherapy. Abstract Cancer immunotherapy represents a significant advancement in cancer treatment by enhancing the specific recognition and elimination of cancer cells.
Shilong Zhao, Rui Qu, Zan Dai, Xiqun Jiang, Xu Zhen   +4 more
wiley   +1 more source

Subcutaneous immunotherapy-induced IgG1 suppresses allergic airway inflammation through FcγRIIb-mediated inhibition of group 2 innate lymphoid cell proliferation. [PDF]

World Allergy Organ J
Matsuda M, Hirano A, Morishita M, Fukuda R, Shimora H, Sannomiya Y, Utsumi D, Ohashi-Doi K, Nabe T.   +8 more
europepmc   +1 more source

From Inflammatory Bowel Disease to Cancer: Gut Microbiota–Immune Microenvironment Crosstalk and Natural Product‐Based Therapeutic Opportunities

Cancer Nexus, EarlyView.
ABSTRACT Inflammatory bowel disease (IBD), primarily Crohn's disease and ulcerative colitis, is a chronic relapsing inflammatory disorder of the gastrointestinal tract and an important risk factor for IBD‐associated cancer. Increasing evidence suggests that gut microbiota dysbiosis, epithelial barrier dysfunction, and immune microenvironment remodeling
Xue Zhang, Chongchong Gao, Rui Jiang, Zijian Wu, Jian Bai   +4 more
wiley   +1 more source